Intra-patient stability of tumor mutational burden from tissue biopsies at different time points in advanced cancers

Abstract Background Tumor mutational burden (TMB) may be a predictive biomarker of immune checkpoint inhibitor (ICI) responsiveness. Genomic landscape heterogeneity is a well-established cancer feature. Molecular characteristics may differ even within the same tumor specimen and undoubtedly evolve w...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Timothy V. Pham, Aaron M. Goodman, Smruthy Sivakumar, Garrett Frampton, Razelle Kurzrock
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2021-10-01
coleção:	Genome Medicine
Assuntos:	Tumor mutational burden Immunotherapy Immunotherapy effect on TMB TMB over time TMB over treatment
Acesso em linha:	https://doi.org/10.1186/s13073-021-00979-8
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!